-

New Line of Electrochemistry Bench Meters Simplify pH, Conductivity and Dissolved Oxygen Measurement

Thermo Scientific Orion Lab Star Bench Meters are easy to use, reliable and compact, bringing versatility to academic and water quality laboratories

CHELMSFORD, Mass.--(BUSINESS WIRE)--Academic and industry laboratories now have access to a new line of electrochemistry bench meters from Thermo Fisher Scientific that have been designed to easily record accurate measurements of pH, conductivity and dissolved oxygen. The new line features a compact form for easy storage and can also export data and calibration logs to meet GLP/GMP reporting standards.

Thermo Scientific Orion Lab Star Bench Meters have been designed for ease-of-use and are ideal for users with varying levels of technical expertise, from laboratory managers and scientists, to students and laboratory technicians. The instruments also feature large backlit display screens for easy reading and recording of sample measurements.

“For 60 years, the Orion meters portfolio has set the standard for quality in analytical testing, empowering customers to meet a wide range of application needs in the field and laboratory,” said Denzil Vaughn, vice president and general manager for growth protection and separation at Thermo Fisher Scientific. “As the latest addition to the Orion portfolio and one of the most accessible, the Lab Star Bench Meter allows all users, from novice to experienced expert, to produce accurate readings with confidence.”

Thermo Scientific Orion Lab Star Bench Meters are well-suited for academic, water quality and other laboratories seeking a flexible and easy-to-use instrument for electrochemistry testing. Combined with Thermo Scientific Orion Electrodes and Solutions, Orion Lab Star Meters offer an economical option for reliable testing and measuring pH, conductivity and dissolved oxygen parameters.

For more information about the Thermo Scientific Orion Lab Star Bench Meter, please visit thermofisher.com/electrochemistry.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom